Work

Supplemantary Figure S2 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma

Year: 2023

Type: other

Abstract: Clinical outcomes by CD74 categorical expression (both number and intensity) in tumor cells (A) in discovery and (B) in validation datasets of stage III melanoma patients. Kaplan-Meier analyses are shown for OS and RFS.

DOI: 10.1158/1078-0432.22459298.v1

Authors: Suhendan Ekmekcioglu, Michael A. Davies, Keiji Tanese, Jason Roszik, Myung Shin-Sim, Roland L. Bassett, Denái R. Milton, Scott E. Woodman, Victor G. Prieto, Jeffrey E. Gershenwald, Donald L. Morton, Dave S. Hoon, Elizabeth A. Grimm

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361918562

Cites:

Cited by:

Related to: 10